Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
  • About Us
    • Editorial Profile
    • Editorial Calendar
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
 
 
 
 
  • The Zika Virus Grew Deadlier With A Small Mutation Study Suggests

    The New York Times | A single variation in its DNA may have helped equip the virus to attack fetal cells, contributing to a surge of birth defects in Latin America.

    Sep 28, 2017
  • As Consumer DNA Testing Grows, Two States Resist

    MIT Technology Review | Maryland and New York still restrict who can order genetic tests and how companies can market them.

    Sep 28, 2017
  • Celgene’s Big Data IQ

    Bio-IT World | In recent years, Celgene has been doubling down on its information analytics capabilities, and in January it launched an internal big data platform to more cohesively manage data to drive decision-making from pre-clinical research through commercialization.

    Sep 28, 2017
  • The drug-makers guide to the galaxy

    Nature News & Comment | How machine learning and big data are helping chemists search the vast chemical universe for better medicines.

    Sep 26, 2017
  • Deep Genomics Raises $13 Million To Develop Genetic Medicines

    Bio-IT World Brief | Deep Genomics received a USD $13 million equity investment led by Khosla Ventures. They are accompanied by early stage investment firm True Ventures. In the next three years, Deep Genomics will use its platform to unlock new classes of anti-sense oligonucleotide therapies that were previously inaccessible, and advance them for clinical evaluation.

    Sep 25, 2017
  • Congenica, PerkinElmer, Illumina, And More: News From September 2017

    Bio-IT World | September featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Congenica, PerkinElmer, Illumina, and more.

    Sep 25, 2017
  • Jackson Lab Files Federal Complaint, Accusing Chinese University Of Selling Its Mice

    Hartford Courant | The Jackson Laboratory is suing to stop Nanjing University, whom it accuses of selling offspring of the genomics center’s mice used for research.

    Sep 22, 2017
  • Even At $500K, Gene Therapy Could Be A Bargain For Some Diseases

    MIT Technology Review | A one-time gene therapy that costs half a million dollars sounds crazy until you add up what it costs to treat some diseases over a lifetime.

    Sep 21, 2017
  • CRISPR Used To Peer Into Human Embryo's First Days

    Nature News & Comment | Gene-edited embryos enable researchers to unpick role of a crucial gene, with more studies likely to follow.

    Sep 20, 2017
  • Edico Genome’s DRAGEN Now Available On Illumina’s BaseSpace Sequence Hub

    Bio-IT World Brief | Edico Genome today announced the availability of its DRAGEN Bio-IT Platform on Illumina’s BaseSpace Sequence Hub, enabling users to now run DRAGEN instances to enhance the accuracy and speed of their secondary analysis of next-generation sequencing data.

    Sep 19, 2017
  • «
  • 331
  • 332
  • 333
  • 334
  • 335
  • 336
  • 337 (current)
  • 338
  • 339
  • 340
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: [email protected]

Twitter Icon LinkedIn Icon Facebook Icon

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy